“Improvement of Risk Assessment in Cutaneous Melanoma (CM) by a Prognostic 31-Gene Expression Profile (31-GEP) Test over AJCC-Based Staging Alone”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S70. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/466.